Design of inhibitors of BCRP/ABCG2. - Wikidata - wikimedia - TriplyDB

Design of inhibitors of BCRP/ABCG2.

Design of inhibitors of BCRP/ABCG2.

http://www.wikidata.org/entity/Q38570549

about

Identification of Febuxostat as a New Strong ABCG2 Inhibitor: Potential Applications and Risks in Clinical Situations.ABCG2/BCRP: Specific and Nonspecific Modulators.

P2860

Q37533506-A77099FD-A442-4641-A6BF-6A8549AE4105 Q39049159-918BCEC2-95E9-4DD4-AB7B-C867AA3CB41B

P2860

Design of inhibitors of BCRP/ABCG2.

http://www.wikidata.org/entity/Q38570549

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Design of inhibitors of BCRP/ABCG2.

@en

type

label

Design of inhibitors of BCRP/ABCG2.

@en

prefLabel

Design of inhibitors of BCRP/ABCG2.

@en

P1433

Q38570549-6B43EFAC-DDBE-4870-992B-870C1AD16963

P1476

Q38570549-D9690EE2-A8FD-4F76-B001-92D974DE0423

P2093

Q38570549-5B0587E2-19A8-4EAC-B229-F1A2BD268520

P2860

Q38570549-04FD27E5-8CA2-4E71-AFF3-894B7AED7ADF

Q38570549-07480A76-C413-4978-AD2A-4D978376637C

Q38570549-09474C33-21EA-4DDA-B547-D78CC7B428E0

Q38570549-0CB34ED7-8565-422E-8B74-E81D03D3B866

Q38570549-19168DDF-DC58-4C27-9629-643988A30A04

Q38570549-561BD7B9-6761-4097-97FC-A53B18CA1976

Q38570549-6290494A-ED88-45B6-A45B-421CD97509F1

Q38570549-72A7EB8E-1D33-47D1-9B17-66426D2139AE

Q38570549-75540C45-AEAE-4DC4-A222-B8D4E5B4C344

Q38570549-77843EDB-3D69-4451-A664-A588BE29052D

P304

Q38570549-06D62699-E604-4FA4-A589-4592DE3E719E

P31

Q38570549-C1158E99-DF7B-4937-825C-CA0B105403AA

P356

Q38570549-3823D534-B411-4722-A902-5467C47A156B

P433

Q38570549-9BC56485-AF22-4032-89F7-7FB67EEC1AAD

P478

Q38570549-3EDD563D-6959-4EE2-978A-0ED5AC893E45

P50

Q38570549-A33F58FD-625E-4534-AA42-7D742B08CA33

P577

Q38570549-C3334C89-1D48-42CB-968A-A93334B47408

P698

Q38570549-5927FF95-E78C-420E-95DF-F951E15D719F

P356

P1433

Future Medicinal Chemistry

P1476

Design of inhibitors of BCRP/ABCG2

@en

P2093

Michael Wiese

http://www.w3.org/2001/XMLSchema#string

P2860

A multidrug resistance transporter from human MCF-7 breast cancer cells

Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2).

Functionalized chalcones as selective inhibitors of P-glycoprotein and breast cancer resistance protein.

Distribution of gefitinib to the brain is limited by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2)-mediated active efflux

Investigation of chalcones and benzochalcones as inhibitors of breast cancer resistance protein.

Synthesis and biological evaluation of flavones and benzoflavones as inhibitors of BCRP/ABCG2.

Investigation of quinazolines as inhibitors of breast cancer resistance protein (ABCG2).

Role of the breast cancer resistance protein (ABCG2) in drug transport.

Inhibitors of cancer cell multidrug resistance mediated by breast cancer resistance protein (BCRP/ABCG2).

Investigation of chalcones as selective inhibitors of the breast cancer resistance protein: critical role of methoxylation in both inhibition potency and cytotoxicity

P304

1521-1527

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4155/FMC.15.83

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-08-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26293476

http://www.w3.org/2001/XMLSchema#string